|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online August 31, 2007
Journal of Experimental Biology 210, 3301-3310 (2007)
Published by The Company of Biologists 2007
doi: 10.1242/jeb.006106
Ventilatory and cardiovascular actions of centrally administered trout tachykinins in the unanesthetized trout
1 Laboratoire de Traitement de l'Information Médicale, INSERM U650,
and Laboratoire de Neurophysiologie, Faculté de Médecine et des
Sciences de la Santé, Université de Bretagne Occidentale, 22
avenue Camille Desmoulins, CS 93837, 29238 Brest Cedex 3, France
2 Department of Biochemistry, Faculty of Medicine and Health Sciences,
United Arab Emirates University, 17666 Al Ain, United Arab Emirates
* Author for correspondence (e-mail: jean-claude.lemevel{at}univ-brest.fr)
Accepted 17 July 2007
The brains of teleost fish contain members of the tachykinin family that
are the products of orthologous genes expressed in mammalian nervous tissues,
but little is known regarding the physiological effects of these peptides in
their species of origin. The present study compares the central actions of
trout neuropeptide gamma (NP
), substance P (SP) and neurokinin A (NKA)
(5–250 pmol) on ventilatory and cardiovascular parameters in the
unanesthetized rainbow trout Oncorhynchus mykiss.
Intracerebroventricular (ICV) injection of NP
evoked a dose-dependent
elevation of the ventilation rate (fV) but a reduction of
the ventilation amplitude (VAMP) that was caused by a
reduction of the magnitude of the adduction phase of the ventilatory signal.
The net effect of NP
was to produce an hypoventilatory response since
the total ventilation (VTOT) was significantly reduced.
The minimum effective dose for a significant effect of NP
on
fV and VAMP was 50 pmol. SP evoked a
significant elevation of fV, a concomitant depression of
VAMP, and a resultant decrease in VTOT
but only at the highest dose (250 pmol). NKA was without action on
fV but significantly decreased VAMP at
only the highest dose tested. In this case also, the net effect of NKA was to
reduce VTOT. When injected centrally, none of the three
peptides, at any dose tested, produced changes in heart rate or mean dorsal
aortic blood pressure (PDA). Intra-arterial injection of
the three tachykinins (250 pmol) produced a significant (P<0.05)
increase in PDA, but only SP and NKA induced concomitant
bradycardia. None of the three peptides produced any change in
fV or VAMP. In conclusion, our results
demonstrate that centrally injected tachykinins, particularly NP
,
produce a strong hypoventilatory response in a teleost fish and so suggest
that endogenous tachykinins may be differentially implicated in
neuroregulatory control of ventilation.
Key words: neuropeptide
, substance P, neurokinin A, ventilatory control, intracerebroventricular injection, teleost
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J.-C. Le Mevel, F. Lancien, N. Mimassi, and J. M. Conlon Ventilatory and cardiovascular actions of centrally and peripherally administered trout pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) in the unanaesthetized trout J. Exp. Biol., December 1, 2009; 212(23): 3919 - 3927. [Abstract] [Full Text] [PDF] |
||||